University of Newcastle Australia-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

    The Lancet Neurology, Vol. 23, Núm. 8, pp. 775-786

2023

  1. Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget’s disease of bone

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 4, pp. 529-536

2022

  1. Editorial: Sensing the World Through Predictions and Errors

    Frontiers in Human Neuroscience

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The Role of Glutamate Neurotransmission in Mismatch Negativity (MMN), A Measure of Auditory Synaptic Plasticity and Change-detection

    Neuroscience, Vol. 456, pp. 106-113

2020

  1. Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort

    Journal of Bone and Mineral Research, Vol. 35, Núm. 7, pp. 1246-1252

  2. The effect of NMDA-R antagonist, MK-801, on neuronal mismatch along the rat auditory thalamocortical pathway

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

    BMJ Open, Vol. 9, Núm. 9

2016

  1. The neurobiology of MMN and implications for schizophrenia

    Biological Psychology, Vol. 116, pp. 90-97

  2. Understanding the neurobiology of MMN and its reduction in schizophrenia

    Biological Psychology